Dispensary Roundup: Harvest Health Opens Two Shops In Fla., SKYMINT In Michigan, Cresco And Ayr Wellness Open One Store Each in PA
Harvest Health & Recreation Opens Two Medical Cannabis Stores In Florida Ahead Of Merger With Trulieve
Dispensary Roundup: Trulieve Opens Two Stores In Florida, BC Cannabis Store And Cultivate Each Open Shops
Trulieve Opens Stores In Tampa And Tavernier, 89th and 90th Dispensary Nationwide
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) continues its June opening streak by launching dispensaries in Tampa and Tavernier.
These OTC Securities had the Most Trading Activity in May
Photo by Karsten Winegeart on Unsplash
The Week In Cannabis: Federal Research Bill, George Lopez, Brazil, Morocco, Columbia Care And More
As we near the end of the first half of 2021, we can see cannabis stocks traded mostly up by double digits, with the Amplify Seymour Cannabis ETF (NYSE: CNBS) delivering gains of more than 50% year-to-date.
This week, however, stocks posted mixed performances.
Video: Benzinga Cannabis Insider 6/10 Ft. Platinum Vape And Glass House Group
Benzinga’s Cannabis Insider is a live daily show for cannabis investors.
EXCLUSIVE: Trulieve CEO On Harvest Deal, Shifting Cannabis Industry Focus, Social Equity
Trulieve Cannabis Corporation (OTCQX: TCNNF) CEO Kim Rivers opened day two of the Benzinga Cannabis Capital Conference Friday with Cheddar Reporter Chloe Aiello.
Cantor Reaffirms Overweight Rating On Cresco Stock Post Earnings Based On The Company’s Franchise Strength
Vertically integrated cannabis company Cresco Labs Inc.
Cannabis Dispensary Roundup: Trulieve To Debut In Massachusetts, Harvest Health Opens 10th Pennsylvania Store, Cannabis Jacks Expands In Ontario
Trulieve Enters Massachusetts With Store In Northampton
Cannabis company Trulieve Cannabis Corp. (CSE: TRUL) (OTC: TCNNF) is poised to debut its products in Massachusetts in a Northampton shop.
The Week In Cannabis: Trulieve’s $2.1B Acquisition, New ETF, Earnings, Federal Legalization And More
In a week of big M&A news and mixed earnings reports, cannabis stocks traded mostly down.
Cantor Fitzgerald Maintains Overweight on Trulieve Cannabis, Lowers Price Target to $71
Cantor Fitzgerald analyst Pablo Zuanic maintains Trulieve Cannabis (OTC:TCNNF) with a Overweight and lowers the price target from $76 to $71.